MSH|^~\&|LABDAQ|Lenco^33D1012663^CLIA|NYSDOH|ECLRS|201606301311||ORU^R01||P|2.3||||PID|1|L136853|L136853||BARRIENTOS^FLOR^^||19720503|F|||1762 EAST 53RD STREET^^BROOKLYN^NY^11234||9175530736|||||||||||||||||||||||OBR|1||1937640|1825^SYPHILIS SEROLOGY^L^86781^^CPT|||201507021727|||IBI|A|||201507022102|S&Serum|48139^SLAVIN^MARTIN^5322 AVENUE N^^^^P|(718)444-7040||||||||FNTE|1|L|NO SEROLOGICAL EVIDENCE OF INFECTION. INCUBATING OR EARLY PRIMARY SYPHILIS CANNOT BE EXCLUDED.ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|1|ST|1825^ANTI-TREPONEMAL ABS (IGG/IGM)^L^63464-2^ANTI-TREPONEMAL ABS (IGG/IGM)^LN||UNDETECTED|INDEX||N|||F|||201507031340|Lenco^33D1012663^CLIA|IBI|||OBR|2||1937640|4510^CMP^L^80053^^CPT|||201507021727|||~AV|A|||201507022102|S&Serum|48139^SLAVIN^MARTIN^5322 AVENUE N^^^^P|(718)444-7040||||||||FZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|1|NM|4600^GLUCOSE^L^2345-7^GLUCOSE^LN||71|mg/dL|70-99||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|2|NM|4605^SODIUM^L^2951-2^SODIUM^LN||138|mEq/L|136-145||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|3|NM|4610^POTASSIUM^L^2823-3^POTASSIUM^LN||4.1|mEq/L|3.7-5.3||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|4|NM|4615^CHLORIDE^L^2075-0^CHLORIDE^LN||103|mEq/L|98-107||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|5|NM|4620^CARBON DIOXIDE^L^2028-9^CARBON DIOXIDE^LN||26|mEq/L|21-31||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|6|NM|4625^UREA NITROGEN^L^3094-0^UREA NITROGEN^LN||9.0|mg/dL|7.0-25.0||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|7|NM|4627^ANION GAP^L^33037-3^ANION GAP^LN||9.00|mEq/L|||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|8|NM|4630^CREATININE^L^2160-0^CREATININE^LN||0.7|mg/dL|0.6-1.3||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|9|NM|4632^BUN/CREATININE RATIO^L^3097-3^BUN/CREATININE RATIO^LN||12.9|Ratio|||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|10|NM|4635^CALCIUM^L^17861-6^CALCIUM^LN||9.2|mg/dL|8.9-10.3||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|11|NM|4640^PROTEIN, TOTAL^L^2885-2^PROTEIN, TOTAL^LN||7.4|g/dL|6.4-8.9||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|12|NM|4645^ALBUMIN^L^1751-7^ALBUMIN^LN||3.7|g/dL|3.7-5.3||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|13|NM|4650^BILIRUBIN, TOTAL^L^1975-2^BILIRUBIN, TOTAL^LN||0.30|mg/dL|0.30-1.00||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|14|NM|4655^ALKALINE PHOSPHATASE^L^6768-6^ALKALINE PHOSPHATASE^LN||51|U/L|34-104||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|15|NM|4660^AST^L^1920-8^AST^LN||17|U/L|13-39||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||ZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|16|NM|4665^ALT^L^1742-6^ALT^LN||14|U/L|7-52||||F|||201507030615|Lenco^33D1012663^CLIA|~AV|||OBR|3||1937640|6066^HEPATITIS C IGG ABS^L^86803^^CPT|||201507021727|||OK|A|||201507022102|S&Serum|48139^SLAVIN^MARTIN^5322 AVENUE N^^^^P|(718)444-7040||||||||FZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|1|ST|6066^HEPATITIS C ABS^L^5198-7^HEPATITIS C ABS^LN||NEGATIVE||||||F|||201507031241|Lenco^33D1012663^CLIA|OK|||OBR|4||1937640|6092^HEPATITIS B SURF. AG /W REFLEX CONFIRMATION^L^87340^^CPT|||201507021727|||MM|A|||201507022102|S&Serum|48139^SLAVIN^MARTIN^5322 AVENUE N^^^^P|(718)444-7040||||||||FZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|1|ST|6092^HEP. B SURF. AG. QUAL^L^5196-1^HEP. B SURF. AG. QUAL^LN||NEGATIVE|INDEX|||||F|||201507031332|Lenco^33D1012663^CLIA|MM|||OBR|5||1937640|6505^HEPATITIS A TOTAL ABS^L^86708^^CPT|||201507021727|||OK|A|||201507022102|S&Serum|48139^SLAVIN^MARTIN^5322 AVENUE N^^^^P|(718)444-7040||||||||FZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|1|ST|6505^HEPATITIS A ABS^L^13951-9^HEPATITIS A ABS^LN||NEGATIVE||||||F|||201507031241|Lenco^33D1012663^CLIA|OK|||OBR|6||1937640|6515^HEPATITIS B SURFACE ABS^L^86706^^CPT|||201507021727|||MM|A|||201507022102|S&Serum|48139^SLAVIN^MARTIN^5322 AVENUE N^^^^P|(718)444-7040||||||||FZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|1|NM|6515^HEPATITIS B SURFACE ABS^L^10900-9^HEPATITIS B SURFACE ABS^LN||50.29|mIU/mL|<10.00|H|||F|||201507031332|Lenco^33D1012663^CLIA|MM|||OBR|7||1937640|6520^HEPATITIS B CORE TOTAL ABS^L^86704^^CPT|||201507021727|||OK|A|||201507022102|S&Serum|48139^SLAVIN^MARTIN^5322 AVENUE N^^^^P|(718)444-7040||||||||FZLR||SLAVIN,MARTIN, M.D.|5322 AVENUE N^^BROOKLYN^NY^11234||||||OBX|1|ST|6520^HEPATITIS B CORE ABS^L^13952-7^HEPATITIS B CORE ABS^LN||NEGATIVE||||||F|||201507031241|Lenco^33D1012663^CLIA|OK|||MSH|^~\&|LABDAQ|Lenco^33D1012663^CLIA|NYSDOH|ECLRS|201606301312||ORU^R01||P|2.3||||PID|1|L65576|L65576||LOTT^JOSEPH^^||19350613|M|||1220 FLATLANDS AVE 2L^^BROOKLYN^NY^11207||7182573183|||||||||||||||||||||||OBR|1||1938282|4510^CMP^L^80053^^CPT|||201507021846|||~AV|A|||201507022228|S&Serum|100048^OGUNFOWORA^OLUSEGUN^FAR^^^^P|(718)327-7307||||||||FZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|1|NM|4600^GLUCOSE^L^2345-7^GLUCOSE^LN||100|mg/dL|70-99|H|||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|2|NM|4605^SODIUM^L^2951-2^SODIUM^LN||140|mEq/L|136-145||||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|3|NM|4610^POTASSIUM^L^2823-3^POTASSIUM^LN||3.6|mEq/L|3.7-5.3|L|||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|4|NM|4615^CHLORIDE^L^2075-0^CHLORIDE^LN||105|mEq/L|98-107||||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|5|NM|4620^CARBON DIOXIDE^L^2028-9^CARBON DIOXIDE^LN||25|mEq/L|21-31||||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|6|NM|4625^UREA NITROGEN^L^3094-0^UREA NITROGEN^LN||21.0|mg/dL|7.0-25.0||||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|7|NM|4627^ANION GAP^L^33037-3^ANION GAP^LN||10.00|mEq/L|||||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|8|NM|4630^CREATININE^L^2160-0^CREATININE^LN||1.1|mg/dL|0.7-1.3||||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|9|NM|4632^BUN/CREATININE RATIO^L^3097-3^BUN/CREATININE RATIO^LN||19.1|Ratio|||||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|10|NM|4635^CALCIUM^L^17861-6^CALCIUM^LN||9.0|mg/dL|8.9-10.3||||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|11|NM|4640^PROTEIN, TOTAL^L^2885-2^PROTEIN, TOTAL^LN||7.1|g/dL|6.4-8.9||||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|12|NM|4645^ALBUMIN^L^1751-7^ALBUMIN^LN||3.9|g/dL|4.2-5.5|L|||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|13|NM|4650^BILIRUBIN, TOTAL^L^1975-2^BILIRUBIN, TOTAL^LN||1.60|mg/dL|0.30-1.00|H|||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|14|NM|4655^ALKALINE PHOSPHATASE^L^6768-6^ALKALINE PHOSPHATASE^LN||55|U/L|34-104||||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|15|NM|4660^AST^L^1920-8^AST^LN||28|U/L|13-39||||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|16|NM|4665^ALT^L^1742-6^ALT^LN||34|U/L|7-52||||F|||201507030641|Lenco^33D1012663^CLIA|~AV|||OBR|2||1938282|6535^HIV-1 RNA, REAL TIME PCR^L^^^CPT|||201507021846|||MR|A|||201507022228|S&Serum|100048^OGUNFOWORA^OLUSEGUN^FAR^^^^P|(718)327-7307||||||||FZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|1|ST|6535^HIV-1 RNA^L^23876-6^HIV-1 RNA^LN||NOT DETECTED|COPIES/ML|<20||||F|||201507090929|Lenco^33D1012663^CLIA|MR|||ZLR||MULTIVIZ HEALTH SERVICES|529 BEACH 20TH ST^^Far Rockaway^NY^11691||||||OBX|2|ST|6536^HIV-1 RNA (LOG10)^L^29539-4^HIV-1 RNA (LOG10)^LN||< 1.18|LOG10|<1.31||||F|||201507090929|Lenco^33D1012663^CLIA|MR|||MSH|^~\&|LABDAQ|Lenco^33D1012663^CLIA|NYSDOH|ECLRS|201606301312||ORU^R01||P|2.3||||PID|1|273873|273873||CHIBPS^9221^^||19921214|M|||^^^^|||||||||||||||||||||||||OBR|1||1947424|6381^HIV-1/2 ANTIBODY DIFFERENTIATION^L^^^CPT|||201507141431|||OK|A|||201507142234|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|6375^HIV 1 ANTIBODY^L^69668-2^HIV 1 ANTIBODY^LN||POSITIVE|||A|||F|||201507201121|Lenco^33D1012663^CLIA|OK|||ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|2|ST|6380^HIV 2 ANTIBODY^L^69668-2^HIV 2 ANTIBODY^LN||NEGATIVE||||||F|||201507201121|Lenco^33D1012663^CLIA|OK|||MSH|^~\&|LABDAQ|Lenco^33D1012663^CLIA|NYSDOH|ECLRS|201606301312||ORU^R01||P|2.3||||PID|1|244482|244482||CHIBPS^9385^^||19901028|M|||^^^^|||||||||||||||||||||||||OBR|1||1976295|6381^HIV-1/2 ANTIBODY DIFFERENTIATION^L^^^CPT|||201508171718|||OK|A|||201508172002|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||CNTE|1|L|ASSAY INTERPRETATION: HIV-1 POSITIVENTE|2|L|NTE|3|L|THIS ASSAY IS INTENDED TO BE USED AS PART OF A MULTI-TEST HIV-1/HIV-2NTE|4|L|DIAGNOSTIC ALGORITHM. IN CONJUNCTION WITH A REPEATEDLY REACTIVE HIV AG/AB ORNTE|5|L|HIV AB SCREENING TEST, A POSITIVE HIV-1 ANTOBODY RESULT CONFIRMS THE PRESENCENTE|6|L|OF HIV-1 INFECTION IN PATIENTS GREATER THAN 24 MONTHS OF AGE.ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|6375^HIV 1 ANTIBODY^L^69668-2^HIV 1 ANTIBODY^LN||POSITIVE|||A|||F|||201509011238|Lenco^33D1012663^CLIA|OK|||ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|2|ST|6380^HIV 2 ANTIBODY^L^69668-2^HIV 2 ANTIBODY^LN||NEGATIVE||||||F|||201509011238|Lenco^33D1012663^CLIA|OK|||ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|3|ST|6385^GEENIUS^L^80203-3^GEENIUS^LN||HIV-1 POSITIVE|||A|||C|||201509011238|Lenco^33D1012663^CLIA|OK|||MSH|^~\&|LABDAQ|Lenco^33D1012663^CLIA|NYSDOH|ECLRS|201606301312||ORU^R01||P|2.3||||PID|1|16232|16232||DOH^PROFICIENCY^^||20040910|M|||^^^^|||||||||||||||||||||||||OBR|1||1998040|6381^HIV-1/2 ANTIBODY DIFFERENTIATION^L^^^CPT|||201509111017|||OK|A|||201509111017|S&Serum|2^DOH^PROFICIENCY^^^^^P|(718)689-2220||||||||FNTE|1|L|ASSAY INTERPRETATION: HIV-1 POSITIVENTE|2|L|NTE|3|L|THIS ASSAY IS INTENDED TO BE USED AS PART OF A MULTI-TEST HIV-1/HIV-2NTE|4|L|DIAGNOSTIC ALGORITHM. IN CONJUNCTION WITH A REPEATEDLY REACTIVE HIV AG/AB ORNTE|5|L|HIV AB SCREENING TEST, A POSITIVE HIV-1 ANTOBODY RESULT CONFIRMS THE PRESENCENTE|6|L|OF HIV-1 INFECTION IN PATIENTS GREATER THAN 24 MONTHS OF AGE.ZLR|||^^^^||||||OBX|1|ST|6375^HIV 1 ANTIBODY^L^69668-2^HIV 1 ANTIBODY^LN||POSITIVE|||A|||F|||201509151536|Lenco^33D1012663^CLIA|OK|||ZLR|||^^^^||||||OBX|2|ST|6380^HIV 2 ANTIBODY^L^69668-2^HIV 2 ANTIBODY^LN||NEGATIVE||||||F|||201509151536|Lenco^33D1012663^CLIA|OK|||ZLR|||^^^^||||||OBX|3|ST|6385^GEENIUS^L^80203-3^GEENIUS^LN||HIV-1 POSITIVE|||A|||F|||201509151536|Lenco^33D1012663^CLIA|OK|||MSH|^~\&|LABDAQ|Lenco^33D1012663^CLIA|NYSDOH|ECLRS|201606301312||ORU^R01||P|2.3||||PID|1|16235|16235||DOH^PROFICIENCY^^||20040910|M|||^^^^|||||||||||||||||||||||||OBR|1||1998043|6381^HIV-1/2 ANTIBODY DIFFERENTIATION^L^^^CPT|||201509111018|||OK|A|||201509111018|S&Serum|2^DOH^PROFICIENCY^^^^^P|(718)689-2220||||||||FNTE|1|L|ASSAY INTERPRETATION: HIV-1 POSITIVENTE|2|L|NTE|3|L|THIS ASSAY IS INTENDED TO BE USED AS PART OF A MULTI-TEST HIV-1/HIV-2NTE|4|L|DIAGNOSTIC ALGORITHM. IN CONJUNCTION WITH A REPEATEDLY REACTIVE HIV AG/AB ORNTE|5|L|HIV AB SCREENING TEST, A POSITIVE HIV-1 ANTOBODY RESULT CONFIRMS THE PRESENCENTE|6|L|OF HIV-1 INFECTION IN PATIENTS GREATER THAN 24 MONTHS OF AGE.ZLR|||^^^^||||||OBX|1|ST|6375^HIV 1 ANTIBODY^L^69668-2^HIV 1 ANTIBODY^LN||POSITIVE|||A|||F|||201509151537|Lenco^33D1012663^CLIA|OK|||ZLR|||^^^^||||||OBX|2|ST|6380^HIV 2 ANTIBODY^L^69668-2^HIV 2 ANTIBODY^LN||NEGATIVE||||||F|||201509151537|Lenco^33D1012663^CLIA|OK|||ZLR|||^^^^||||||OBX|3|ST|6385^GEENIUS^L^80203-3^GEENIUS^LN||HIV-1 POSITIVE|||A|||F|||201509151537|Lenco^33D1012663^CLIA|OK|||MSH|^~\&|LABDAQ|Lenco^33D1012663^CLIA|NYSDOH|ECLRS|201606301312||ORU^R01||P|2.3||||PID|1|331262|331262||CHIBPS^10267^^||19930616|M|||^^^^|||||||||||||||||||||||||OBR|1||2008712|845^RPR^L^86592^^CPT|||201509221326|||JC|A|||201509222136|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|5057^RPR^L^20507-0^RPR^LN||NONREACTIVE||||||F|||201509241543|Lenco^33D1012663^CLIA|JC|||OBR|2||2008712|1825^SYPHILIS SEROLOGY^L^86781^^CPT|||201509221326|||IBI|A|||201509222136|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|1825^ANTI-TREPONEMAL ABS (IGG/IGM)^L^63464-2^ANTI-TREPONEMAL ABS (IGG/IGM)^LN||DETECTED|INDEX||A|||F|||201509241321|Lenco^33D1012663^CLIA|IBI|||OBR|3||2008712|5117^CHLAMYDIA TRACH. rRNA URINE^L^87491^^CPT|||201509221326|||DLS|A|||201509222136|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|5117^CHLAMYDIA TRACHOMATIS rRNA URINE^L^42931-6^CHLAMYDIA TRACHOMATIS rRNA URINE^LN||NEGATIVE||||||F|||201509231741|Lenco^33D1012663^CLIA|DLS|||OBR|4||2008712|5119^N. GONORRHOEAE rRNA URINE^L^87591^^CPT|||201509221326|||DLS|A|||201509222136|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|5119^NEISSERIA GONORRHOEAE rRNA URINE^L^60256-5^NEISSERIA GONORRHOEAE rRNA URINE^LN||NEGATIVE||||||F|||201509231741|Lenco^33D1012663^CLIA|DLS|||OBR|5||2008712|6381^HIV-1/2 ANTIBODY DIFFERENTIATION^L^^^CPT|||201509221326|||OK|A|||201509222136|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FNTE|1|L|ASSAY INTERPRETATION: HIV-1 POSITIVENTE|2|L|NTE|3|L|THIS ASSAY IS INTENDED TO BE USED AS PART OF A MULTI-TEST HIV-1/HIV-2NTE|4|L|DIAGNOSTIC ALGORITHM. IN CONJUNCTION WITH A REPEATEDLY REACTIVE HIV AG/AB ORNTE|5|L|HIV AB SCREENING TEST, A POSITIVE HIV-1 ANTOBODY RESULT CONFIRMS THE PRESENCENTE|6|L|OF HIV-1 INFECTION IN PATIENTS GREATER THAN 24 MONTHS OF AGE.ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|6375^HIV 1 ANTIBODY^L^69668-2^HIV 1 ANTIBODY^LN||POSITIVE|||A|||F|||201509251427|Lenco^33D1012663^CLIA|OK|||ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|2|ST|6380^HIV 2 ANTIBODY^L^69668-2^HIV 2 ANTIBODY^LN||NEGATIVE||||||F|||201509251427|Lenco^33D1012663^CLIA|OK|||ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|3|ST|6385^GEENIUS^L^80203-3^GEENIUS^LN||HIV-1 POSITIVE|||A|||F|||201509251427|Lenco^33D1012663^CLIA|OK|||MSH|^~\&|LABDAQ|Lenco^33D1012663^CLIA|NYSDOH|ECLRS|201606301312||ORU^R01||P|2.3||||PID|1|007|007||BOND^JAMES^^||19810222|M|||123 MAIN ST^APT 3B^Brooklyn^NY^11214||7186892220|||S|||111223344|||||||||||||||||OBR|1||2031068|6381^HIV-1/2 ANTIBODY DIFFERENTIATION^L^^^CPT|||201510141636|||FS|A|||201510141636|S&Serum|5^UNKNOWN^DOCTOR^^^^^P|(718)232-1515||||||||FNTE|1|L|ASSAY INTERPRETATION: HIV-1 POSITIVENTE|2|L|NTE|3|L|THIS ASSAY IS INTENDED TO BE USED AS PART OF A MULTI-TEST HIV-1/HIV-2NTE|4|L|DIAGNOSTIC ALGORITHM. IN CONJUNCTION WITH A REPEATEDLY REACTIVE HIV AG/AB ORNTE|5|L|HIV AB SCREENING TEST, A POSITIVE HIV-1 ANTOBODY RESULT CONFIRMS THE PRESENCENTE|6|L|OF HIV-1 INFECTION IN PATIENTS GREATER THAN 24 MONTHS OF AGE.ZLR||Test doctor|1857 86th Street^GI^Brooklyn^NY^11214||||||OBX|1|ST|6375^HIV 1 ANTIBODY^L^69668-2^HIV 1 ANTIBODY^LN||POSITIVE|||A|||F|||201510141637|Lenco^33D1012663^CLIA|FS|||ZLR||Test doctor|1857 86th Street^GI^Brooklyn^NY^11214||||||OBX|2|ST|6380^HIV 2 ANTIBODY^L^69668-2^HIV 2 ANTIBODY^LN||NEGATIVE||||||F|||201510141637|Lenco^33D1012663^CLIA|FS|||ZLR||Test doctor|1857 86th Street^GI^Brooklyn^NY^11214||||||OBX|3|ST|6385^GEENIUS^L^80203-3^GEENIUS^LN||HIV-1 POSITIVE|||A|||F|||201510141637|Lenco^33D1012663^CLIA|FS|||OBR|2||2031068|10634^HIV-1/2 AG + ABS, 5TH GEN W/ REFLEX^L^86703^^CPT|||201510141636|||FS|A|||201510141636|S&Serum|5^UNKNOWN^DOCTOR^^^^^P|(718)232-1515||||||||FZLR||Test doctor|1857 86th Street^GI^Brooklyn^NY^11214||||||OBX|1|ST|704^HIV-1/2 AG + ABS, 4TH GEN W/ REFLEX^L^56888-1^HIV-1/2 AG + ABS, 4TH GEN W/ REFLEX^LN||REACTIVE|||A|||F|||201510141636|Lenco^33D1012663^CLIA|FS|||MSH|^~\&|LABDAQ|Lenco^33D1012663^CLIA|NYSDOH|ECLRS|201606301312||ORU^R01||P|2.3||||PID|1|336596|336596||CHIBPS^10386^^||19921204|M|||^^^^|||||||||||||||||||||||||OBR|1||2032674|1825^SYPHILIS SEROLOGY^L^86781^^CPT|||201510150949|||JC|A|||201510151959|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FNTE|1|L|NO SEROLOGICAL EVIDENCE OF INFECTION. INCUBATING OR EARLY PRIMARY SYPHILIS CANNOT BE EXCLUDED.ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|1825^ANTI-TREPONEMAL ABS (IGG/IGM)^L^63464-2^ANTI-TREPONEMAL ABS (IGG/IGM)^LN||UNDETECTED|INDEX||N|||F|||201510161257|Lenco^33D1012663^CLIA|JC|||OBR|2||2032674|5117^CHLAMYDIA TRACH. rRNA URINE^L^87491^^CPT|||201510150949|||ST|A|||201510151959|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|5117^CHLAMYDIA TRACHOMATIS rRNA URINE^L^42931-6^CHLAMYDIA TRACHOMATIS rRNA URINE^LN||NEGATIVE||||||F|||201510161646|Lenco^33D1012663^CLIA|ST|||OBR|3||2032674|5119^N. GONORRHOEAE rRNA URINE^L^87591^^CPT|||201510150949|||ST|A|||201510151959|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|5119^NEISSERIA GONORRHOEAE rRNA URINE^L^60256-5^NEISSERIA GONORRHOEAE rRNA URINE^LN||NEGATIVE||||||F|||201510161646|Lenco^33D1012663^CLIA|ST|||OBR|4||2032674|6381^HIV-1/2 ANTIBODY DIFFERENTIATION^L^^^CPT|||201510150949|||OK|A|||201510151959|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FNTE|1|L|ASSAY INTERPRETATION: HIV-1 POSITIVENTE|2|L|NTE|3|L|THIS ASSAY IS INTENDED TO BE USED AS PART OF A MULTI-TEST HIV-1/HIV-2NTE|4|L|DIAGNOSTIC ALGORITHM. IN CONJUNCTION WITH A REPEATEDLY REACTIVE HIV AG/AB ORNTE|5|L|HIV AB SCREENING TEST, A POSITIVE HIV-1 ANTOBODY RESULT CONFIRMS THE PRESENCENTE|6|L|OF HIV-1 INFECTION IN PATIENTS GREATER THAN 24 MONTHS OF AGE.ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|6375^HIV 1 ANTIBODY^L^69668-2^HIV 1 ANTIBODY^LN||POSITIVE|||A|||F|||201510201200|Lenco^33D1012663^CLIA|OK|||ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|2|ST|6380^HIV 2 ANTIBODY^L^69668-2^HIV 2 ANTIBODY^LN||NEGATIVE||||||F|||201510201200|Lenco^33D1012663^CLIA|OK|||ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|3|ST|6385^GEENIUS^L^80203-3^GEENIUS^LN||HIV-1 POSITIVE|||A|||F|||201510201200|Lenco^33D1012663^CLIA|OK|||OBR|5||2032674|10634^HIV-1/2 AG + ABS, 5TH GEN W/ REFLEX^L^86703^^CPT|||201510150949|||DK|A|||201510151959|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FNTE|1|L|REPEATED BY DUPLICATE ANALYSISZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|704^HIV-1/2 AG + ABS, 4TH GEN W/ REFLEX^L^56888-1^HIV-1/2 AG + ABS, 4TH GEN W/ REFLEX^LN||REACTIVE|||A|||F|||201510161617|Lenco^33D1012663^CLIA|DK|||MSH|^~\&|LABDAQ|Lenco^33D1012663^CLIA|NYSDOH|ECLRS|201606301312||ORU^R01||P|2.3||||PID|1|260324|260324||CHIBPS^7643^^||19901218|M|||^^^^|||||||||||||||||||||||||OBR|1||2046271|6381^HIV-1/2 ANTIBODY DIFFERENTIATION^L^^^CPT|||201510291622|||OK|A|||201510292150|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FNTE|1|L|ASSAY INTERPRETATION: HIV-1 POSITIVENTE|2|L|NTE|3|L|THIS ASSAY IS INTENDED TO BE USED AS PART OF A MULTI-TEST HIV-1/HIV-2NTE|4|L|DIAGNOSTIC ALGORITHM. IN CONJUNCTION WITH A REPEATEDLY REACTIVE HIV AG/AB ORNTE|5|L|HIV AB SCREENING TEST, A POSITIVE HIV-1 ANTOBODY RESULT CONFIRMS THE PRESENCENTE|6|L|OF HIV-1 INFECTION IN PATIENTS GREATER THAN 24 MONTHS OF AGE.ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|6375^HIV 1 ANTIBODY^L^69668-2^HIV 1 ANTIBODY^LN||POSITIVE|||A|||F|||201511041154|Lenco^33D1012663^CLIA|OK|||ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|2|ST|6380^HIV 2 ANTIBODY^L^69668-2^HIV 2 ANTIBODY^LN||NEGATIVE||||||F|||201511041154|Lenco^33D1012663^CLIA|OK|||ZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|3|ST|6385^GEENIUS^L^80203-3^GEENIUS^LN||HIV-1 POSITIVE|||A|||F|||201511041154|Lenco^33D1012663^CLIA|OK|||OBR|2||2046271|10634^HIV-1/2 AG + ABS, 5TH GEN W/ REFLEX^L^86703^^CPT|||201510291622|||DK|A|||201510292150|S&Serum|520034^GREENE^RICHARD^411 LAFAYETTE 5TH FL^^^^P|(212)998-5600||||||||FNTE|1|L|REPEATED BY DUPLICATE ANALYSISZLR||CHIBPS NYU 5 YEAR STUDY|411 LAFAYETTE STREET 5TH FLOOR^^NEW YORK^NY^10003||||||OBX|1|ST|704^HIV-1/2 AG + ABS, 4TH GEN W/ REFLEX^L^56888-1^HIV-1/2 AG + ABS, 4TH GEN W/ REFLEX^LN||REACTIVE|||A|||F|||201510301530|Lenco^33D1012663^CLIA|DK|||